As of Oct 2, 2026 close
- Market cap
- $1.53M
- P/E (TTM)
- —
- Forward P/E
- —
- Dividend yield
- —
- 52-week range
- $0.19$3.66
- Volume (live)
- —
- Avg. volume (3M)
- 150.34K
Calidi Biotherapeutics (CLDI) Stock Price & Financial Analysis
Calidi Biotherapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.05 - $1.09 |
|---|---|
| 52-Week High | $3.66 |
| 52-Week Low | $0.19 |
| Open | $1.09 |
| Volume (last close) | 38.62K |
| Average Volume (3M) | 150.34K |
| Market Cap | 1.53M |
|---|---|
| Shares Outstanding | 1.42M |
| Price to Book (P/B) | 0.49 |
| EV/EBITDA | 0.05 |
| 50-Day MA | $1.38 |
|---|---|
| 200-Day MA | $1.42 |
| 52-Week Change | −30.77% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Calidi Biotherapeutics at a Glance
Calidi Biotherapeutics (CLDI) has a market capitalization of $1.53M.
It holds $4.07M in cash and securities against $1.78M of debt, a net cash position of $2.29M.
Calidi Biotherapeutics does not currently pay a dividend.
The share price is down 32.5% over the past year. At $1.08 it sits within its 52-week range of $0.19 to $3.66, below its 200-day moving average of $1.42.
Frequently Asked Questions About Calidi Biotherapeutics
What is the current stock price for CLDI?
As of the Oct 2, 2026 close, CLDI stock trades at $1.08. The 52-week range is $0.19–$3.66, with a day range of $1.05–$1.09.
What is the P/E ratio for CLDI?
The P/E ratio (Price-to-Earnings) for CLDI is shown in the Key Statistics section. This valuation metric helps compare Calidi Biotherapeutics, Inc. to industry peers.
Does CLDI pay dividends?
Calidi Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CLDI?
Analyst ratings and recommendations for CLDI are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CLDI?
Calidi Biotherapeutics's market capitalization is $1.5M, classifying it as a micro-cap company. Calidi Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.